Key Events This Week
21 Sep: Mixed technical signals amid price momentum shift
22 Sep: Mojo Grade upgraded to Buy on strong fundamentals
23 Sep: Bullish technical momentum signals emerge
25 Sep: Technical momentum shifts amid mixed indicator signals
Oct 01, 11:40 AM
BSE+NSE Vol: 4.13 lacs

Extending its winning streak to five consecutive sessions, Shukra Pharmaceuticals Ltd surged 5.17% on 1 Oct 2026 to close at Rs 65.25, just 0.42% shy of its 52-week high. This rally has propelled the stock to a fresh all-time high, significantly outpacing the broader Sensex which remained flat on the day.
Read full news article
Shukra Pharmaceuticals Ltd has demonstrated a significant shift in price momentum, supported by a series of bullish technical indicators that have upgraded its outlook from mildly bullish to outright bullish. The stock’s recent performance, combined with positive signals from MACD, moving averages, and Bollinger Bands, suggests a strengthening trend that investors should closely monitor.
Read full news article
21 Sep: Mixed technical signals amid price momentum shift
22 Sep: Mojo Grade upgraded to Buy on strong fundamentals
23 Sep: Bullish technical momentum signals emerge
25 Sep: Technical momentum shifts amid mixed indicator signals

Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a blend of bullish and bearish signals across multiple timeframes. Despite a modest day decline of 2.11%, the stock’s recent upgrades and technical indicators suggest a cautiously optimistic outlook for investors.
Read full news article
Shukra Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating following a marked improvement in its technical indicators, robust financial trends, and sustained quality metrics. The micro-cap pharmaceutical company’s recent performance has outpaced market benchmarks, prompting a reassessment of its investment appeal.
Read full news article
Shukra Pharmaceuticals Ltd has demonstrated a significant shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its Mojo Grade from Hold to Buy. The micro-cap pharmaceutical company’s shares surged 6.32% on 23 Sep 2026, closing at ₹58.73, signalling renewed investor confidence amid a broader positive technical trend.
Read full news article
Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend as of mid-September 2026. Despite a recent downgrade from a Buy to a Hold rating by MarketsMOJO, the stock’s price action and technical indicators reveal a complex interplay of bullish and bearish signals, reflecting cautious optimism in the micro-cap pharmaceutical sector.
Read full news article
15 Sep: Mojo Grade downgraded to Hold amid mixed technicals and expensive valuation
16 Sep: Technical momentum shifts to mildly bullish with mixed indicator signals
18 Sep: Technical trend upgraded to bullish despite slight price dip

Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a slight dip in the stock price on 18 Sep 2026, the evolving technical indicators suggest a potential strengthening in price momentum, warranting close attention from investors and market analysts alike.
Read full news articleVoting Results and Scrutinizers Report
Voting Results with Scrutinizer Report
Outcome of AGM
No Upcoming Board Meetings
Shukra Pharmaceuticals Ltd has declared 1% dividend, ex-date: 21 Sep 26
Shukra Pharmaceuticals Ltd has announced 1:10 stock split, ex-date: 21 Mar 25
Shukra Pharmaceuticals Ltd has announced 3:1 bonus issue, ex-date: 19 Apr 24
Shukra Pharmaceuticals Ltd has announced 6:1 rights issue, ex-date: 02 Feb 23